Skip to main content
Journal of Advanced Pharmaceutical Technology & Research logoLink to Journal of Advanced Pharmaceutical Technology & Research
. 2026 Feb 9;17(1):71–77. doi: 10.4103/JAPTR.JAPTR_157_25

Proteomic profiling and regenerative potential of bovine placental extract in wound healing models

Julian Arbey Gonzalez Ospina 1, Erika M Muñoz Martinez 1, Sebastian Hernandez Sampa 1, Juan S Gomez 1, Mauricio Palacios 1, Alvaro A Barrera-Ocampo 1,✉
PMCID: PMC12981714  PMID: 41836782

ABSTRACT

The placenta is rich in proteins and metabolites that modulate repair processes. Bovine placental extract (BPE) offers a practical alternative to human-derived materials for regenerative applications. The study aimed to characterize the proteomic composition of BPE and evaluate its regenerative potential in vitro and in vivo. Proteins were profiled by liquid chromatography–tandem mass spectrometry and analyzed through bioinformatic enrichment of signaling pathways. Regenerative activity was assessed in New Zealand rabbit excisional wounds and human fibroblast cultures using viability and scratch assays. A total of 204 proteins were identified, including 89 differentially expressed proteins enriched in transforming growth factor-β, WNT, and extracellular matrix pathways. Topical BPE accelerated wound closure in rabbits compared with saline controls (P < 0.05). In fibroblasts, viability remained above 80% across all concentrations, and migration showed a nonsignificant dose-dependent trend. BPE contains bioactive proteins linked to key repair pathways and enhances wound healing without cytotoxic effects. These results support its potential as a safe, accessible biomaterial for regenerative medicine.

Keywords: Cell signaling, placenta, protein expression, skin, tissue regeneration

INTRODUCTION

The skin rarely regains full structural and functional integrity after injury, as scar tissue restores only about 80% of its original strength and elasticity.[1] In some cases, hypertrophic or keloid scars may also impair appearance and quality of life.[2] Wound repair proceeds through overlapping stages of hemostasis, inflammation, proliferation, and tissue remodeling, coordinated by fibroblasts, stromal cells, and growth factors that regulate key signaling pathways.[3,4]

The placenta is a rich source of biomolecules with therapeutic potential, but its clinical use is constrained by ethical concerns.[5] Placental extracts promote angiogenesis and tissue repair through growth factors and matrix proteins,[6,7,8] yet their molecular mechanisms remain unclear. Bovine placenta represents a practical and ethically acceptable alternative to human tissue. However, its proteomic composition and regenerative effects are poorly defined, and few studies have explored its influence on fibroblast behavior or wound healing. Previous evidence suggests that bovine placental extract (BPE) may activate pathways involved in tissue repair, including transforming growth factor (TGF)-β and WNT signaling cascades.[6,7,9,10]

This study is novel in that it integrates proteomic analysis of bovine placenta extract with functional assays in animal and fibroblast models. Its aim was to provide insight into protein pathways potentially involved in tissue repair and to evaluate the regenerative effects of BPE in vivo and in vitro, offering new evidence for its application as a scalable biomaterial in regenerative medicine.

MATERIALS AND METHODS

Materials

Dulbecco’s Modified Eagle Medium (DMEM), fetal bovine serum (FBS), and antibiotic–antimycotic solution were obtained from Thermo Fisher Scientific (Massachusetts, USA). BPEs were supplied by Natural Herbeats (Colombia).

Mass spectrometry and proteomic analysis

Protein concentration was determined using the bicinchoninic acid (BCA) assay. Samples were precipitated with cold acetone, reduced, alkylated, and digested overnight with trypsin. Peptides were analyzed by liquid chromatography–tandem mass spectrometry on an Orbitrap instrument under standard data-dependent acquisition settings.

Raw data from two independent BPE batches (five technical replicates each) were processed in MaxQuant (v1.6.2.17) (MAxQuant: Computational Systems Biochemistry Group, Max-Planck Institute of Biochemistry, Martinsried, Munich, Germany) against the UniProt Bos taurus reference proteome (UP000009136). Label-free quantification (LFQ) values were log2-transformed, contaminants and reverse hits removed, and missing values imputed (MNAR method). Differential expression was evaluated using limma, with proteins considered significant at adjusted P ≤ 0.05 and | log2 fold change | ≥1.

Functional enrichment and pathway analyses were performed using LFQ-Analyst,[11] WebGestalt,[12] and STRING[13] to identify overrepresented biological processes and signaling clusters.

Animal model and wound healing study

Five adult New Zealand rabbits (two males and three females; 2.3–3.8 kg) were housed under standard conditions at Universidad Icesi (Cali, Colombia). Procedures complied with Colombian animal welfare regulations (Laws 84 / 1989, 1774 / 2016, Resolution 8430 / 1993) and were approved by the Institutional Animal Ethical Committee (CIECUAE/2023, June 16, 2023).

Four 3 mm excisional wounds were created on the dorsal surface of each animal under anesthesia. Wounds were treated daily for 14 days with either phosphate-buffered saline or 1% BPE (200 μL/wound). Photographs were taken throughout healing, and wound area was quantified using ImageJ.[14]

Cell culture and viability assay

Human fibroblast 1BR3 cells (ECACC No. 90011801) were cultured in DMEM supplemented with 10% FBS, 1% sodium pyruvate, 1% L-glutamine, and 1% penicillin/streptomycin at 37°C in 5% CO2.

For viability assays, 2 × 105 cells/well were seeded in 24-well plates and treated with BPE at 10, 100, or 1000 μg/mL, or saline control, for 72 h. Cell viability was determined by trypan blue exclusion and expressed as the percentage of unstained cells relative to total counts.

Scratch (migration) assay

Fibroblasts were seeded in 24-well plates (2 × 105 cells/well) and allowed to adhere for 24 h. A uniform scratch (~2 mm) was generated using standardized neodymium magnets to ensure consistent width. After washing, media containing BPE (10–1000 μg/mL) or controls were added in triplicate. Images were taken at 0 h and 72 h, and wound closure percentage was quantified using ImageJ[14] software (ImageJ: National Institutes of Health, Washington, D.C. USA; and the Laboratory for Optical and Computational Instrumentation (LOCI, University of Wisconsin), Wisconsin, USA). Percentage reduction was calculated as:

graphic file with name JAPTR-17-71-g001.jpg

Statistical analysis

Analyses were performed with GraphPad Prism 10 (La Jolla, CA, USA). Data normality was tested by Shapiro–Wilk. Normally distributed wound healing data (five animals and four wounds each) were compared by t-test. Nonparametric data (cell viability and migration; ≥3 independent experiments) were analyzed with the Kruskal–Wallis test and Dunn’s post hoc comparisons. The results were expressed as mean ± standard error of the mean, with significance set at P < 0.05.

RESULTS

Proteomic profile of bovine placenta extracts

Proteomic profiling of two independent BPE batches identified 204 proteins, including 89 that were differentially expressed (≥2-fold change, P < 0.05) [Figure 1a]. Among these, 64 mapped to unique Entrez Gene IDs. Gene Ontology (GO) classification revealed enrichment in metabolic processes, response to stimuli, and biological regulation, with most proteins localized to the extracellular space, nucleus, and protein complexes [Figure 1b]. These results indicate that BPE contains bioactive proteins associated with tissue repair and wound healing.

Figure 1.

Figure 1

Differential protein abundance and functional enrichment analysis. (a) Volcano plot showing differentially abundant proteins between bovine placental extract batches. (b) Gene Ontology (GO) enrichment of upregulated proteins classified by biological process, cellular component, and molecular function

Network analysis of upregulated proteins revealed 12 functional clusters [Supplementary Table 1], of which clusters 2 and 3 were most relevant to regeneration. Cluster 2 included pathways related to TGF-β receptor signaling, cellular senescence, DNA replication, transcriptional regulation, and WNT signaling [Table 1 and Figure 2a]. Cluster 3 comprised extracellular matrix (ECM) processes such as collagen fibril assembly, ECM organization, and degradation [Figure 2b]. Collectively, these findings suggested that BPE proteins participate in cell signaling and matrix remodeling processes critical for tissue regeneration.

Supplementary Table 1.

Protein clusters identified in the functional analysis

Cluster Id gene count description
 Cluster 1: 13 AHCY, ASRGL1, CLIC1, EIF5A, FAHD1, FTH1, FTL, GLRX, HSPA9, RPLP2, RPS20, RPS…
 Cluster 2: 12 TGF-beta receptor signaling activates SMADs
 Cluster 3: 11 ECM
 Cluster 4: 11+Lysosome
 Cluster 5: 6+CLEC7A (Dectin-1) induces NFAT activation
 Cluster 6: 5 Digestion
 Cluster 7: 4+Glycosaminoglycan degradation
 Cluster 8: 3 Mixed, incl. Zinc finger, CHHC-type, and Heterogeneous nuclear ribonucleoprotein A…
 Cluster 9: 3 Bactericidal permeability-increasing protein, alpha/beta domain superfamily
 Cluster 10: 2 CKM, MYL1
 Cluster 11: 2 ATP5ME-2, COX6B1
 Cluster 12: 2 AKR1B1, CAPG

TGF: Transforming growth factor, ECM: Extracellular matrix

Table 1.

Proteomic pathways and signaling clusters identified in bovine placenta extracts

Cluster Pathway Description Strength FDR*
2 BTA-2173789 TGF-beta receptor signaling activates SMADs 2.28 0.001
BTA-2559582 SASP 1.79 0.0081
BTA-68867 Assembly of the prereplicative complex 1.67 0.0108
BTA-8878171 Transcriptional regulation by RUNX1 1.53 0.016
BTA-201681 TCF-dependent signaling in response to WNT 1.47 0.0214
3 BTA-2243919 Crosslinking of collagen fibrils 2.52 0.0169
BTA-3000171 Nonintegrin membrane-ECM interactions 2.28 0.0313
BTA-1442490 Collagen degradation 2.09 0.0346
BTA-3000178 ECM proteoglycans 2.04 0.0371
BTA-1474228 Degradation of the extracellular matrix 1.92 0.0098

*False discovery rate ≤0.05, Strength ≥0.01. SASP: Senescence-associated secretory phenotype, ECM: Extracellular matrix, TGF: Transforming growth factor, TCF: T-cell factor, FDR: False discovery rate

Figure 2.

Figure 2

Functional analysis of up-regulated proteins. (a) Cell signaling pathways in Cluster 2, associated with the TGF-beta receptor complex (R-BTA-2173789), cellular senescence (R-BTA-2559582), initiation of DNA replication (R-BTA-68867), transcription (R-BTA-8878171), and WNT signaling (R-BTA-201681). (b) Signaling pathways in Cluster 3, related to collagen fibril assembly and other multimeric structures (R-BTA-2243919), extracellular matrix organization (R-BTA-3000171, R-BTA-3000178), and extracellular matrix degradation (R-BTA-1474228, R-BTA-1442490). FRD: False discovery rate ≤0.05, Strength ≥0.01

Bovine placental extract improves wound healing in an in vivo model

In the rabbit excisional wound model, topical BPE treatment accelerated closure compared with saline controls [Figure 3a]. Quantitative analysis confirmed significantly smaller wound areas and higher healing percentages in BPE-treated sites (P < 0.05) [Figure 3b and c]. These results demonstrate that BPE enhances wound healing without adverse local reactions.

Figure 3.

Figure 3

BPE enhances wound healing and fibroblast migration without affecting cell viability. (a) In vivo wound healing assay comparing wound recovery after 8 days of treatment with either 0.9% saline solution or 1% BEP. Scale =1.0 mm. (b) Bovine placental extract (BPE) treatment significantly reduced wound area compared with saline (Saline: 6.49 ± 0.25 mm2 vs. BPE: 5.71 ± 0.15 mm2, P = 0.0278). (c) BPE treatment significantly increased the percentage of wound healing (saline: 8.56 ± 1.15% vs. BPE: 22.04 ± 0.81%, P < 0.0001). (d) 1BR3 fibroblast cells exhibit enhanced migration following treatment with 1000 μg/mL BEP. Scale =100 μm. (e) BPE did not affect 1BR3 cell viability at any tested concentration (Vehicle: 100.0 ± 0.00 %, BPE: 1000 μg/mL: 80.40 ± 4.68 %, BPE: 100 μg/mL: 90.95 ± 4.14 %, BPE: 10 μg/mL: 85.12 ± 5.44 %). (f) Migration analysis showing that treatment with 1000 μg/mL BPE produced a nonsignificant trend toward greater wound closure (11.5% ±1.18) compared with 100 μg/mL (7.7% ±5.14) and 10 μg/mL (2.9% ±2.34)

Bovine placental extract does not affect fibroblast viability and shows a trend toward improved migration

To assess cytocompatibility, fibroblasts were treated with increasing BPE concentrations (10–1000 μg/mL) for 72 h. Cell viability remained above 80% at all concentrations, with no significant differences from controls [Figure 3e]. In the scratch assay, migration improved modestly in a dose-dependent manner, although differences were not statistically significant [Figure 3d and f]. Together, these data indicate that BPE is nontoxic to fibroblasts and may stimulate migratory activity.

DISCUSSION

The placenta is rich in growth factors and bioactive molecules that promote key processes in wound healing.[6,9,15,16] In this study, BPE enhanced wound closure in rabbits and maintained fibroblast viability, suggesting that its regenerative effects are more pronounced in complex tissue environments than in isolated cell systems.

Proteomic profiling identified 204 proteins, including 89 that differed significantly between batches. Enrichment and network analyses highlighted two main clusters related to tissue regeneration. Cluster 2 comprised pathways associated with TGF-β/SMAD activation, cellular senescence, DNA replication, transcriptional regulation, and WNT signaling. Activation of TGF-β1 promotes ECM deposition, fibroblast differentiation, and wound contraction in animal models.[17]

The Senescence-Associated Secretory Phenotype was another cluster-2 pathway, characterized by growth factor and cytokine secretion by senescent cells,[18] which facilitates repair through immune recruitment and paracrine signaling. Transient fibroblast senescence enhances regeneration via PDGFA secretion in knockout mouse models.[19,20] Additional cluster-2 pathways such as prereplicative complex assembly and RUNX1-mediated transcription regulate DNA replication, cell cycle progression, and stem cell activity.[21,22]

WNT/β-catenin signaling also appeared in this cluster, influencing fibroblast proliferation and stem cell renewal through β-catenin-dependent transcription.[23] Crosstalk between WNT/β-catenin and TGF-β pathways likely underlies the regenerative activity of BPE. Although this interpretation derives from enrichment analysis rather than direct validation, it provides a mechanistic framework for future studies using targeted molecular assays such as Western blotting or qPCR.

Cluster 3 was enriched in ECM organization and turnover pathways, including collagen fibril assembly, ECM-cell interactions, and proteoglycan-mediated signaling. Collagen cross-linking and degradation by metalloproteinases are essential for tissue strength and remodeling during angiogenesis and epithelialization.[24,25,26] The coexistence of anabolic and catabolic ECM proteins in BPE suggests balanced matrix renewal, consistent with effective repair.

Together, these clusters represent complementary mechanisms that drive proliferation and differentiation, and ECM-remodeling processes that restore tissue architecture. Growth factors and structural proteins within BPE may act synergistically to promote repair, highlighting its potential as a biologically active biomaterial.

This study is novel in that it integrates proteomic characterization of BPE with functional wound-healing assays in animal and fibroblast models. It provides new evidence for the application of BPE as a scalable alternative to human placental preparations. Nevertheless, some limitations must be considered. The in vivo work involved a small number of animals and a single concentration, limiting statistical power and dose–response interpretation. Future studies should include larger wounds, multiple concentrations, and histological analyses to strengthen translational relevance. The in vitro assays relied on a nonstandard scratch technique and a basic trypan blue viability test; complementary methods such as live–dead staining or impedance monitoring could provide greater precision. Proteomic results were obtained from two production batches, offering preliminary insights but insufficient to fully evaluate batch-to-batch variability. Additional targeted proteomic validation and bioassays are required to confirm the role of the identified pathways.

Despite these constraints, the combined findings demonstrate that BPE contains proteins associated with regenerative pathways and shows measurable in vivo effects, supporting its potential as a safe and accessible biomaterial for regenerative medicine.

CONCLUSIONS

Placental extracts represent a promising class of biomaterials for tissue repair and regeneration. This study demonstrates that BPE contains proteins involved in TGF-β, WNT, and ECM signaling pathways associated with wound healing. BPE accelerated tissue repair in vivo and preserved fibroblast viability in vitro, supporting its safety and biological activity. These findings highlight BPE as an alternative to human placental preparations and provide a foundation for future studies exploring its clinical potential in regenerative medicine.

Conflicts of interest

There are no conflicts of interest.

Acknowledgment

We thank the animal facility of Icesi University and Jody Cardenas for their support in the experiments with animal models.

Funding Statement

This work was funded by Universidad Icesi – Convocatoria de Apoyo a Doctorado (JAGO), (Grant No. CA0413110, Colombia) and the Company Naturals Herbeats (Grant No. 04030916, Colombia).

REFERENCES

  • 1.Wilkinson HN, Hardman MJ. Wound healing: cellular mechanisms and pathological outcomes. Open Biol. 2020;10:1–14. doi: 10.1098/rsob.200223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Wu J, Zou J, Yang Q, Wang H, Tian H, Chen L, et al. The effects of scar in psychological disorder: A bibliometric analysis from, 2003 to 2022. Int Wound J. 2024;21:e14373. doi: 10.1111/iwj.14373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Tottoli EM, Dorati R, Genta I, Chiesa E, Pisani S, Conti B. Skin wound healing process and new emerging technologies for skin wound care and regeneration. pharmaceutics. 2020;12:735. doi: 10.3390/pharmaceutics12080735. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Takeo M, Lee W, Ito M. Wound healing and skin regeneration. Cold Spring Harb Perspect Med. 2015;5:a023267. doi: 10.1101/cshperspect.a023267. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Yoshizawa RS. Review: Public perspectives on the utilization of human placentas in scientific research and medicine. Placenta. 2013;34:9–13. doi: 10.1016/j.placenta.2012.10.014. [DOI] [PubMed] [Google Scholar]
  • 6.Pogozhykh O, Prokopyuk V, Figueiredo C, Pogozhykh D. Placenta and Placental Derivatives in Regenerative Therapies: Experimental Studies, History, and Prospects. Stem Cells Int 2018. 2018:1–14. doi: 10.1155/2018/4837930. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Shukla VK, Rasheed MA, Kumar M, Gupta SK, Pandey SS. A trial to determine the role of placental extract in the treatment of chronic non-healing wounds. J Wound Care. 2004;13:177–9. doi: 10.12968/jowc.2004.13.5.26668. [DOI] [PubMed] [Google Scholar]
  • 8.Chandanwale A, Langade D, Mohod V, Sinha S, Ramteke A, Bakhshi GD, et al. Comparative evaluation of human placental extract for its healing potential in surgical wounds after orthopaedic surgery: An open, randomised, comparative study. J Indian Med Assoc. 2008;106:405–8. [PubMed] [Google Scholar]
  • 9.Bryant-Greenwood GD. The extracellular matrix of the human fetal membranes: Structure and function. Placenta. 1998;19:1–11. doi: 10.1016/s0143-4004(98)90092-3. [DOI] [PubMed] [Google Scholar]
  • 10.Ghatak S, Maytin EV, Mack JA, Hascall VC, Atanelishvili I, Moreno Rodriguez R, et al. Roles of proteoglycans and glycosaminoglycans in wound healing and fibrosis. Int J Cell Biol. 2015;2015:834893. doi: 10.1155/2015/834893. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Shah AD, Goode RJ, Huang C, Powell DR, Schittenhelm RB. LFQ-analyst: An easy-to-use interactive web platform to analyze and visualize label-free proteomics data preprocessed with maxquant. J Proteome Res. 2020;19:204–11. doi: 10.1021/acs.jproteome.9b00496. [DOI] [PubMed] [Google Scholar]
  • 12.Wang J, Duncan D, Shi Z, Zhang B. WEB-based GEne SeT AnaLysis toolkit (WebGestalt): Update 2013. Nucleic Acids Res. 2013;41:W77–83. doi: 10.1093/nar/gkt439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, Hachilif R, et al. The STRING database in, 2023: Protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 2023;51:D638–46. doi: 10.1093/nar/gkac1000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: An open-source platform for biological-image analysis. Nat Methods. 2012;9:676–82. doi: 10.1038/nmeth.2019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Meinert M, Eriksen GV, Petersen AC, Helmig RB, Laurent C, Uldbjerg N, et al. Proteoglycans and hyaluronan in human fetal membranes. Am J Obstet Gynecol. 2001;184:679–85. doi: 10.1067/mob.2001.110294. [DOI] [PubMed] [Google Scholar]
  • 16.Hauguel-de Mouzon S, Guerre-Millo M. The placenta cytokine network and inflammatory signals. Placenta. 2006;27:794–8. doi: 10.1016/j.placenta.2005.08.009. [DOI] [PubMed] [Google Scholar]
  • 17.Au K, Ehrlich HP. When the Smad signaling pathway is impaired, fibroblasts advance open wound contraction. Exp Mol Pathol. 2010;89:236–40. doi: 10.1016/j.yexmp.2010.08.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Kumari R, Jat P. Mechanisms of cellular senescence: Cell cycle arrest and senescence associated secretory phenotype. Front Cell Dev Biol. 2021;9:645593. doi: 10.3389/fcell.2021.645593. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Acosta JC, Banito A, Wuestefeld T, Georgilis A, Janich P, Morton JP, et al. Acomplex secretory program orchestrated by the inflammasome controls paracrine senescence. Nat Cell Biol. 2013;15:978–90. doi: 10.1038/ncb2784. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Demaria M, Ohtani N, Youssef SA, Rodier F, Toussaint W, Mitchell JR, et al. An essential role for senescent cells in optimal wound healing through secretion of PDGF-AA. Dev Cell. 2014;31:722–33. doi: 10.1016/j.devcel.2014.11.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Dimitrova DS, Prokhorova TA, Blow JJ, Todorov IT, Gilbert DM. Mammalian nuclei become licensed for DNA replication during late telophase. J Cell Sci. 2002;115:51–9. doi: 10.1242/jcs.115.1.51. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Hoi CS, Lee SE, Lu SY, McDermitt DJ, Osorio KM, Piskun CM, et al. Runx1 directly promotes proliferation of hair follicle stem cells and epithelial tumor formation in mouse skin. Mol Cell Biol. 2010;30:2518–36. doi: 10.1128/MCB.01308-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Liu J, Xiao Q, Xiao J, Niu C, Li Y, Zhang X, et al. Wnt/?-catenin signalling: Function, biological mechanisms, and therapeutic opportunities. Signal Transduct Target Ther. 2022;7:3. doi: 10.1038/s41392-021-00762-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Mathew-Steiner SS, Roy S, Sen CK. Collagen in wound healing. Bioengineering (Basel) 2021;8:63. doi: 10.3390/bioengineering8050063. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Potekaev NN, Borzykh OB, Medvedev GV, Pushkin DV, Petrova MM, Petrov AV, et al. The role of extracellular matrix in skin wound healing. J Clin Med. 2021;10:5947. doi: 10.3390/jcm10245947. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Lu P, Takai K, Weaver VM, Werb Z. Extracellular matrix degradation and remodeling in development and disease. Cold Spring Harb Perspect Biol. 2011;3:a005058. doi: 10.1101/cshperspect.a005058. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Advanced Pharmaceutical Technology & Research are provided here courtesy of Wolters Kluwer -- Medknow Publications

RESOURCES